Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2003-11-17
pubmed:abstractText
To test the efficacy of an ultra-short intravenous triple therapy against Helicobacter pylori infection in patients with bleeding peptic ulcer against standard oral 1-week triple therapy in a randomised, double-blind prospective trial.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0269-2813
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1023-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14616169-Amoxicillin, pubmed-meshheading:14616169-Anti-Bacterial Agents, pubmed-meshheading:14616169-Anti-Ulcer Agents, pubmed-meshheading:14616169-Clarithromycin, pubmed-meshheading:14616169-Clavulanic Acids, pubmed-meshheading:14616169-Double-Blind Method, pubmed-meshheading:14616169-Drug Administration Schedule, pubmed-meshheading:14616169-Drug Combinations, pubmed-meshheading:14616169-Duodenal Ulcer, pubmed-meshheading:14616169-Female, pubmed-meshheading:14616169-Helicobacter Infections, pubmed-meshheading:14616169-Helicobacter pylori, pubmed-meshheading:14616169-Humans, pubmed-meshheading:14616169-Infusions, Intravenous, pubmed-meshheading:14616169-Male, pubmed-meshheading:14616169-Middle Aged, pubmed-meshheading:14616169-Omeprazole, pubmed-meshheading:14616169-Peptic Ulcer Hemorrhage, pubmed-meshheading:14616169-Recurrence, pubmed-meshheading:14616169-Stomach Ulcer, pubmed-meshheading:14616169-Treatment Failure
pubmed:year
2003
pubmed:articleTitle
Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer.
pubmed:affiliation
Digestive and Hepatology Unit, Hospital Universitario de Valme, Seville, Spain. mromerog@supercable.es
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study